OBJECTIVE: This study investigates the molecular epidemiology of orf virus (ORFV) in the Fujian province in 2024, with the goal of gaining insights that can enhance disease prevention and control strategies. METHODS: This experimental study was conducted from January 2024 through March 2024. The samples, showing suspected orf lesions, tested positive for ORFV via PCR. The ORFV059 (F1L) and ORFV011 (B2L) genes from these samples were cloned and sequenced. RESULTS: Analysis identified 3 ORFV strains: FJ-2401, FJ-2402, and FJ-2403. For the F1L gene, nucleotide sequence identity ranged from 95.7% to 99.6%, and amino acid identity ranged from 95.0% to 99.7% compared to the reference strain. These strains were closely related to others from Fujian, Guangzhou, and India but differed from the NZ2 reference strain, the German D1701 weak strain, and Chinese vaccine strains, which were in separate branches. For the B2L gene, nucleotide identity ranged from 97.4% to 99.6%, and amino acid identity ranged from 97.1% to 100%. Evolutionary analysis indicated potential recombination events with strains from Fujian, Jilin, and India. The B2L gene showed distinct branching from the German D1701 weak strain, Fujian GO strain, and Chinese vaccine strains, suggesting that current vaccines might be inadequate. CONCLUSIONS: Viruses are constantly evolving, and currently available commercial vaccines may not provide sufficient protection against emerging ORFV strains. This underscores the urgent need for updated vaccines and improved management strategies. CLINICAL RELEVANCE: The study reveals significant genetic diversity and potential recombination in ORFV strains in Fujian, highlighting their divergence from known references.
C. pseudotuberculosis is a Gram-positive pathogenic bacterium that infects various animals, causing diseases such as caseous lymphadenitis, leading to significant economic losses in the livestock industry and posing zoonotic risks. This study targeted the conserved gyrA gene fragment of this bacterium, designed specific primers, optimized the reaction system and conditions, and established a high-resolution melting curve (HRM) detection method with potential utility for preliminary molecular screening. Validation showed that this method exhibits strong specificity, producing specific amplification only for the target biovars. The melting temperatures (Tm values) for the two biovars were 86.16 ± 0.05 °C and 86.92 ± 0.05 °C, respectively, allowing clear differentiation. It demonstrated high sensitivity, with minimum detection limits of 28 copies/μL and 25 copies/μL for standard plasmids of the ovis and equi biovars, respectively. The method also showed good reproducibility, with intra- and inter-batch coefficients of variation both below 1.0%. Applied to 133 clinical nasal swab samples from goats in Fujian Province, the method detected a positivity rate of 19.5% and indicates that a biovar equi-like gene fragment was detected in goat nasal swabs from Fujian Province via molecular screening. The HRM method developed in this study is sensitive, specific, simple, and cost-effective, enabling rapid detection and biovar differentiation of C. pseudotuberculosis. It is suitable for large-scale clinical sample screening and provides an efficient technical approach for epidemiological monitoring and precise control of the disease.
Orf virus (ORFV) is a major pathogen in goats and sheep, and control currently depends mainly on commercial live vaccines. Although mRNA vaccines have revolutionized human medicine, their use in veterinary settings is largely unexplored. In this study, an mRNA vaccine candidate encoding the ORFV F1L protein (F1L-mRNA-LNP) was developed via in vitro transcription and encapsulated in lipid nanoparticles. BALB/c mice were divided into five groups (n = 14 each): three receiving different doses of F1L-mRNA-LNP (5, 10, or 15 μg), one receiving a commercial live vaccine (CV), and a PBS control group. Mice were immunized intramuscularly and boosted after 14 days; immune responses were assessed 14 days later following ARRIVE 2.0 guidelines. Both the F1L-mRNA-LNP and CV vaccines induced specific antibodies versus PBS (p < 0.01). The 10 μg mRNA group showed Th1 cytokine and CD8+ T cell responses comparable to CV (p > 0.05), whereas IL-4 (Th2) was significantly higher in the CV group (p < 0.05). Neutralizing antibody titers did not differ between groups, indicating that the mRNA vaccine induces comparable Th1 cellular immunity but weaker Th2 humoral immunity. Upon ORFV challenge, the 10 μg F1L-mRNA-LNP vaccine protected BALB/c mice, as evidenced by stable body weight, no clinical symptoms, and reduced viral load, with efficacy comparable to CV (p > 0.05). This study provides strong evidence supporting the optimization of ORFV mRNA vaccines and highlights the translational potential of the F1L-mRNA-LNP candidate vaccine for veterinary applications.
Caseous lymphadenitis (CLA), an infectious disease caused by Corynebacterium pseudotuberculosis (C. pseudotuberculosis), poses a significant economic burden to the global small ruminant industry. This study aimed to investigate genetic variations in the CP40 gene of C. pseudotuberculosis and to develop a rapid detection assay for enhanced pathogen identification. Homology analysis was performed to compare the CP40 gene sequence of the FJ-PN strain with other Corynebacterium species. Specific primers targeting CP40 were designed, and a SYBR Green I-based real-time PCR protocol was optimized. The assay’s specificity, sensitivity, and reproducibility were subsequently validated. The FJ-PN strain exhibited ≥99.65% nucleotide identity and ≥98.94% amino acid identity with C. pseudotuberculosis biovar ovi reference strains, showing 90.18–91.84% nucleotide identity and 88.63–90.77% amino acid identity with C. pseudotuberculosis biovar equi, and ≤82.71% nucleotide identity and ≤78.63% amino acid identity with other Corynebacterium species. The established qPCR assay demonstrated high specificity, the limit of detection was 52 copies/μL, and it demonstrated good reproducibility (intra- and inter-assay CV < 1.0%). Clinical sample testing revealed 18.8% positivity rates in nasal swabs, which was higher than that detected by conventional PCR (16.3%). These results indicate that the CP40 gene is evolutionarily conserved and represents a specific molecular marker for the identification of C. pseudotuberculosis biovar ovis. The developed SYBR Green I real-time PCR assay enables the efficient detection of C. pseudotuberculosis and provides technical support for CLA surveillance and control.
Introduction: Bovine papillomatosis (BP), caused by bovine papillomavirus (BPV), is characterized by proliferative epithelial lesions and is associated with significant economic losses in cattle populations. Despite its clinical and economic relevance, the molecular characteristics of BPV isolates circulating in China, as well as their phylogenetic relationships within the context of global BPV genetic diversity, remain inadequately characterized. Methods: A BPV strain was isolated from a cattle farm in Fujian Province, China, and its complete genomic sequence was obtained. Using publicly available reference sequences, we analyzed the viral L1 gene through recombination screening, selection-pressure analysis (dN/dS ratio), and maximum-likelihood phylogenetic inference. Additional temporal signal analyses were conducted on the BPV2 subset to explore the presence of measurable temporal structure in the sequence data. Results: The newly identified strain, designated FJ-01, was classified as BPV2 and possessed a complete genome of 7,947 bp. No recombination was detected in the L1 gene. The overall dN/dS ratio indicated dominant purifying (negative) selection acting on the L1 gene (dN/dS = 0.0735). Maximum-likelihood phylogenetic analysis placed FJ-01 within the BPV2 clade in the final global L1 dataset. Exploratory temporal analyses of the BPV2 subset suggested weak temporal structure; however, estimates of absolute divergence dates were associated with high uncertainty and should be interpreted with caution. Discussion: This study provides a molecular characterization of a Chinese BPV isolate and integrates it into a global L1-based phylogenetic framework. Our findings support the genetic classification of FJ-01 within BPV2 and indicate the L1 gene is evolutionarily conserved. These results serve as a valuable reference for future molecular surveillance efforts and for more comprehensive studies utilizing geographically balanced and genome-complete BPV datasets.